Medtronic (MDT) just announced the launch of a new clinical study in the U.S. that will test its Hugo robotic-assisted ...

Medtronic’s Hugo surgical robot is making waves in the operating room. This new system aims to bring the benefits of ...

The study aims to validate an integrated surgical ecosystem that combines robotics, imaging, instrumentation and workflow optimisation ...

Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their progress in this roundup of the latest developments in surgical robotics.

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting Primary safety and effectiveness ...

Medtronic plc (NYSE: MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S.

Medtronic has initiated the Embrace Gynecology study in the US to assess the Hugo robotic-assisted surgery (RAS) system's ...

Hugo is already on the market in some countries, but made a slow start commercially. Medtronic cut its sales forecast in 2021, slashing the midpoint of its range from $75 million to $30 million. Sales ...

Medtronic is bringing on a new chief medical officer for its digital and robotics teams, who it described as one of the top five robotic surgeons in the U.S. James Porter serves as medical director of ...

The growth of surgical robots is huge, and this company is looking to get in on the action while it also works to boost its profit margin.